Filtered by Topic
Latest obesity treatment news and updates from Switzerland. AI-curated articles covering obesity treatment topics.
← Show All NewsRoche
Roche says its experimental obesity treatment cut average body weight by 15. 5% after 48 weeks at the highest dose in a mid-stage trial involving overweight or obese patients with type 2 diabetes. Analysts called the results competitive but said larger Phase 3 trials are needed.
20 days ago · 1 source
Roche
Roche subsidiary Genentech has secured worldwide rights, outside South Korea, to develop and market Hanmi Pharmaceutical’s experimental obesity treatment HM17321. The agreement could be worth up to $2. 3 billion, although the drug remains in early-stage clinical trials.
SWI swissinfo.ch
